Nanophase Reports Third Quarter 2019 Financial Results

Announces 56% Growth for Year-Over-Year Formulated Product Sales

The company's financial conference call is scheduled for November 15, 2019 at 4pm EDT

 

Romeoville, IL, - November 14, 2019 - Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based personal care ingredients and formulated products for protecting skin from environmental aggressors, such as UV light and pollution, today reported financial results for the third quarter period ended September 30, 2019.   

“The growth driver in 2019 has been Solesence.  We continue to be optimistic about the future of the business and about the growing demand for minerals-based sunscreens generally.  There has been no slowing down of any of the trends we've seen.  We had fourteen new launches through September 2019 and reorders for the first eight products we launched in 2018.  We expect similar, or greater, Solesence growth through 2020", said Jess Jankowski, the Company's President and CEO.  " Revenue from our largest Personal Care Ingredients customer was down through September and will be down year-over-year.  The comparative reduction was driven from 2018 'spot-buys', inventory builds, and the loss of a significant downstream customer.  This was offset to an extent by a successful new product launch through our largest customer, which we expect to continue to grow in 2020." 

2019 Q3 Financial Information 

Third Quarter 2019 Financial Highlights

  •    -Revenue for the third quarter was $3.1 million in 2019, compared to $4.0 million in 2018.  
  •    -The net loss for the third quarter was $0.9 million, or $0.02 per share, in 2019, compared to a net loss of $0.1 million in 2018, or $0.00 per share, for 2018.
Nine months Ended September 30, 2019 Financial Highlights
  •    -Revenue for the first nine months of 2019 and 2018 was $10.1 million and $11.0 million respectively.  
  •    -The net loss for the first nine months of 2019 was $2.0 million, or $(0.06) per share, compared to a net loss of $1.0 million, or $(0.03) per share, for the comparable period of 2018
  •    -The Company finished the quarter with approximately $1.0 million in cash and cash equivalents. 
Jankowski continued, “While Solesence has had excellent revenue growth during 2019, margins have been lower than anticipated due to inefficiencies in handling higher volume.  We will have much more installed filling capacity by year-end to allow more efficient production.  Additionally, our product mix should be more favorable as we focus on margin improvement.."
 
"Our November 13, 2019 financing, from a strong advocate of our Nanophase and Solesence businesses, has supported us in our recovery form the revenue decline from our largest customer.  We are now focused on building our margins on both new and existing business, with additional growth being important, but secondary to achieving the self-sufficiency that profitability will bring."  Mr. Jankowski reiterated, "Capturing more margin and having it drop to the bottom line is our top focus today.
 
"Our Solesence® finished products and our Personal Care Ingredients are in high demand by the market.  We believe the continued growth of our Solesence business will demonstrate this through 2020, and we expect growth in all of our minerals-based products and ingredients over the coming years."
 
Third Quarter 2019 Conference Call

The Nanophase conference call, to be hosted by Jess Jankowski, the Company’s President & CEO, is scheduled for November 15, 2019, at 3:00 p.m. CST, 4:00 p.m. EST. The conference call dial-in number for U.S. callers is 877-312-8776 and for international callers is 408-774-4007.  The conference ID is 5570428.  Please dial in to the conference at least five minutes before the call is scheduled to begin.  

The call may also be accessed by clicking on the link here to listen to a webcast of the event.

Use of Non-GAAP Financial Information

Nanophase believes that the presentation of results excluding certain items, such as non-cash equity compensation charges, provides meaningful supplemental information to both management and investors, facilitating the evaluation of performance across reporting periods. The Company uses these non-GAAP measures for internal planning and reporting purposes. These non-GAAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. The presentation of this additional information is not meant to be considered in isolation or as a substitute for net income or net income per share prepared in accordance with generally accepted accounting principles. 

About Nanophase Technologies

Nanophase Technologies Corporation (NANX), www.nanophase.com, is a leader in minerals-based personal care ingredients and formulated products for protecting skin from environmental aggressors, such as UV light and pollution, as well as providing solutions for industrial product applications.  Using a platform of patented and proprietary integrated technologies, the Company creates products with unique performance attributes from two ISO 9001 and ISO 14001 registered facilities. Nanophase delivers commercial quantity and quality engineered materials both as ingredients, and as part of fully formulated products, in a variety of formats.   

Forward-Looking Statements

This press release contains words such as “expects,” ”shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s nanocrystalline materials; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company’s Form 10-K filed April 4, 2019. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.